Organ-protective effects on the liver and kidney by minocycline in small piglets undergoing cardiopulonary bypass

[1]  T. Dawson,et al.  Parthanatos: mitochondrial‐linked mechanisms and therapeutic opportunities , 2014, British journal of pharmacology.

[2]  I. Sevrioukova.  Apoptosis-inducing factor: structure, function, and redox regulation. , 2011, Antioxidants & redox signaling.

[3]  C. Krawczeski,et al.  Incidence, risk factors, and outcomes of acute kidney injury after pediatric cardiac surgery: A prospective multicenter study* , 2011, Critical care medicine.

[4]  A. Ündar,et al.  Pediatric Cardiopulmonary Bypass , 2011, World journal for pediatric & congenital heart surgery.

[5]  R. Nieuwland,et al.  Complement activation on the surface of cell-derived microparticles during cardiac surgery with cardiopulmonary bypass - is retransfusion of pericardial blood harmful? , 2011, Perfusion.

[6]  J. Karliner,et al.  Minocycline Protects Cardiac Myocytes Against Simulated Ischemia–Reperfusion Injury by Inhibiting Poly(ADP-ribose) Polymerase-1 , 2010, Journal of cardiovascular pharmacology.

[7]  Zhen Jin,et al.  Protective effects of penehyclidine hydrochloride on liver injury in a rat cardiopulmonary bypass model , 2010, European journal of anaesthesiology.

[8]  W. Stoney.  Evolution of cardiopulmonary bypass. , 2009, Circulation.

[9]  F. Mohr,et al.  Ischemic and inflammatory lung impairment by extracorporeal circulation: effect of PARP-inhibition by INO1001. , 2008, Pharmacological research.

[10]  D. Portilla,et al.  Analytic Reviews: Cardiac Surgery as a Cause of Acute Kidney Injury: Pathogenesis and Potential Therapies , 2008 .

[11]  C. Szabó,et al.  Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors. , 2007, Cardiovascular drug reviews.

[12]  Yingbin Xiao,et al.  Growth hormone prevents acute liver injury induced by cardiopulmonary bypass in a rat model. , 2007, The Journal of thoracic and cardiovascular surgery.

[13]  P. Rhee,et al.  The decreasing incidence of late posttraumatic acute respiratory distress syndrome: the potential role of lung protective ventilation and conservative transfusion practice. , 2007, The Journal of trauma.

[14]  C. Becker,et al.  Pathophysiology of contrast-induced nephropathy. , 2006, The American journal of cardiology.

[15]  R. Swanson,et al.  Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Yeh,et al.  INHIBITION OF POLY(ADP-RIBOSE) POLYMERASE REDUCES CARDIOMYOCYTIC APOPTOSIS AFTER GLOBAL CARDIAC ARREST UNDER CARDIOPULMONARY BYPASS , 2006, Shock.

[17]  C. Szabó.  Cardioprotective effects of poly(ADP-ribose) polymerase inhibition. , 2005, Pharmacological research.

[18]  S. Hagl,et al.  Poly(ADP-ribose) polymerase inhibitor PJ-34 reduces mesenteric vascular injury induced by experimental cardiopulmonary bypass with cardiac arrest. , 2005, American journal of physiology. Heart and circulatory physiology.

[19]  E. Baskın,et al.  Acute Renal Failure and Mortality After Open-Heart Surgery in Infants , 2005, Renal failure.

[20]  S. Hagl,et al.  Poly-ADP-Ribose Polymerase Inhibition Reduces Mesenteric Injury after Cardiopulmonary Bypass* , 2004, The Thoracic and cardiovascular surgeon.

[21]  A. Consolini,et al.  Development of an HPLC method for determination of metabolic compounds in myocardial tissue. , 2004, Journal of pharmaceutical and biomedical analysis.

[22]  S. Hagl,et al.  INO-1001 A NOVEL POLY(ADP-RIBOSE) POLYMERASE (PARP) INHIBITOR IMPROVES CARDIAC AND PULMONARY FUNCTION AFTER CRYSTALLOID CARDIOPLEGIA AND EXTRACORPORAL CIRCULATION , 2004, Shock.

[23]  A. Grayson,et al.  Acute renal failure in coronary artery bypass surgery: independent effect of cardiopulmonary bypass. , 2004, The Annals of thoracic surgery.

[24]  S. Ohri,et al.  A prospective randomized study to evaluate the renoprotective action of beating heart coronary surgery in low risk patients. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[25]  K. Taylor,et al.  Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. , 1999, The Annals of thoracic surgery.

[26]  A. Plessis.  Mechanisms of brain injury during infant cardiac surgery. , 1999 .

[27]  M. Nicholson,et al.  New model of renal warm ischaemia–reperfusion injury for comparative functional, morphological and pathophysiological studies , 1998, The British journal of surgery.

[28]  S. Cuzzocrea,et al.  Peroxynitrite‐induced thymocyte apoptosis: the role of caspases and poly (ADP‐ribose) synthetase (PARS) activation , 1998, Immunology.

[29]  G. Holmes,et al.  Developmental and neurologic status of children after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary arrest , 1995 .

[30]  E. Ingham.  The effects of tetracyclines and erythromycin on complement activation in vitro. , 1990, Acta dermato-venereologica.

[31]  S Westaby,et al.  Complement and the damaging effects of cardiopulmonary bypass. , 1983, Thorax.

[32]  B. Myers,et al.  Acute renal failure following cardiac surgery. , 1979, The Journal of thoracic and cardiovascular surgery.

[33]  Fang Yuan,et al.  Minocycline protects against hepatic ischemia/reperfusion injury in a rat model. , 2015, Biomedical reports.

[34]  F. Mohr,et al.  Reno-protective effects of epigallocatechingallate in a small piglet model of extracorporeal circulation. , 2013, Pharmacological Research.

[35]  G. Kroemer,et al.  NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS AIF: Not Just an Apoptosis-Inducing Factor , 2009 .

[36]  G. Angelini,et al.  Splanchnic organ injury during coronary surgery with or without cardiopulmonary bypass: a randomized, controlled trial. , 2006, The Annals of thoracic surgery.

[37]  E. Kobayashi,et al.  Enhanced responsiveness of circulatory neutrophils after cardiopulmonary bypass: increased aggregability and superoxide producing capacity. , 2000, Artificial organs.

[38]  A. du Plessis.  Mechanisms of brain injury during infant cardiac surgery. , 1999, Seminars in pediatric neurology.

[39]  G. Hill.  The Inflammatory Response to Cardiopulmonary Bypass , 1996, International anesthesiology clinics.

[40]  G. Nisticó,et al.  Nitric oxide release during hypothermic versus normothermic cardiopulmonary bypass. , 1995, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.